The collaboration will expand access to Alzheimer’s biomarker testing through mobile delivery to community centers, churches, and senior centers nationwide.
Read More
Mursla Bio has joined the ABHI US Accelerator program to support the US launch of EvoLiver, an FDA-designated liver cancer surveillance test, gaining access to 300-plus healthcare leaders across 35 hospitals and 20 health systems.
Read More
Johns Hopkins researchers have developed an AI-driven liquid biopsy that uses cell-free DNA fragmentation patterns to detect early liver fibrosis and cirrhosis, according to a study in Science Translational Medicine.
Read More
Thermo Fisher Scientific has opened an $18 million, 8,000-square-meter distribution and labeling center in Uppsala, Sweden, to support global supply of immunodiagnostics for allergy and autoimmune disease testing.
Read More
HerAnova Lifesciences has launched HerResolve, the first blood-based test for endometriosis detection, at IVF centers nationwide. Validation studies show diagnostic accuracy comparable to surgical standards, according to the company.
Read More